Hideaki Ogata
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Invasive Lobular Carcinoma of the Male Breast With BRCA2 Mutation.
Journal: Case reports in pathology
Published: October 13, 2025
Role of ERβ in Triple-Negative Breast Cancer Associated with p53 and Androgen Receptor.
Journal: International journal of molecular sciences
Published: September 24, 2025
Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial.
Journal: The Lancet. Oncology
Published: January 14, 2025
Clinicopathological importance of Bcl-2 and p53 in postmenopausal triple-negative breast carcinoma and association with age.
Journal: Pathology international
Published: November 07, 2023
Comparison between a new assay system, Elecsys® Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study.
Journal: Molecular and clinical oncology
Published: March 09, 2022
Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
Journal: Journal of thyroid research
Published: May 01, 2021
A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients.
Journal: The American journal of case reports
Published: April 22, 2020
Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.
Journal: Journal of clinical pathology
Published: January 19, 2020
Expression of mTOR Signaling Pathway Molecules in Triple-Negative Breast Cancer.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: May 22, 2019
Last Updated: 09/26/2026